Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Association of Genomic Alterations with the Presence of Serum Monoclonal Proteins in Chronic Lymphocytic Leukemia.
Piñeyroa JA, López-Oreja I, Nadeu F, Martínez-Farran A, Aróstegui JI, López-Guerra M, Correa JG, Fabregat A, Villamor N, Monge-Escatín I, Albiol N, Costa D, Aymerich M, Beà S, Campo E, Delgado J, Colomer D, Mozas P. Piñeyroa JA, et al. Among authors: lopez oreja i. Cells. 2024 Nov 7;13(22):1839. doi: 10.3390/cells13221839. Cells. 2024. PMID: 39594588 Free PMC article.
Chronic myelomonocytic leukemia with NPM1 mutation or acute myeloid leukemia?
Castaño-Díez S, Álamo JR, López-Guerra M, Gómez-Hernando M, Zugasti I, Jiménez-Vicente C, Guijarro F, López-Oreja I, Esteban D, Charry P, Torrecillas V, Mont-de Torres L, Cortés-Bullich A, Bataller Á, Guardia A, Munárriz D, Carcelero E, Riu G, Triguero A, Tovar N, Vela D, Beà S, Costa D, Colomer D, Rozman M, Esteve J, Díaz-Beyá M. Castaño-Díez S, et al. Among authors: lopez oreja i. Oncologist. 2024 Sep 30:oyae246. doi: 10.1093/oncolo/oyae246. Online ahead of print. Oncologist. 2024. PMID: 39349391 Free article.
Whole Exome Sequencing of Intermediate-Risk Acute Myeloid Leukemia without Recurrent Genetic Abnormalities Offers Deeper Insights into New Diagnostic Classifications.
Guijarro F, Castaño-Díez S, Jiménez-Vicente C, Garrote M, Álamo JR, Gómez-Hernando M, López-Oreja I, Morata J, López-Guerra M, López C, Beà S, Costa D, Colomer D, Díaz-Beyá M, Rozman M, Esteve J. Guijarro F, et al. Among authors: lopez oreja i. Int J Mol Sci. 2024 Aug 8;25(16):8669. doi: 10.3390/ijms25168669. Int J Mol Sci. 2024. PMID: 39201354 Free PMC article.
Patient-derived follicular lymphoma spheroids recapitulate lymph node signaling and immune profile uncovering galectin-9 as a novel immunotherapeutic target.
Dobaño-López C, Valero JG, Araujo-Ayala F, Nadeu F, Gava F, Faria C, Norlund M, Morin R, Bernes-Lasserre P, Arenas F, Grau M, López C, López-Oreja I, Serrat N, Martínez-Farran A, Hernández L, Playa-Albinyana H, Giménez R, Beà S, Campo E, Lagarde JM, López-Guillermo A, Magnano L, Colomer D, Bezombes C, Pérez-Galán P. Dobaño-López C, et al. Among authors: lopez oreja i. Blood Cancer J. 2024 May 2;14(1):75. doi: 10.1038/s41408-024-01041-7. Blood Cancer J. 2024. PMID: 38697976 Free PMC article.
Chronic lymphocytic leukemia patient-derived xenografts recapitulate clonal evolution to Richter transformation.
Playa-Albinyana H, Arenas F, Royo R, Giró A, López-Oreja I, Aymerich M, López-Guerra M, Frigola G, Beà S, Delgado J, Garcia-Roves PM, Campo E, Nadeu F, Colomer D. Playa-Albinyana H, et al. Among authors: lopez oreja i. Leukemia. 2024 Mar;38(3):557-569. doi: 10.1038/s41375-023-02095-5. Epub 2023 Nov 28. Leukemia. 2024. PMID: 38017105 Free PMC article.
All-CLL: A Capture-based Next-generation Sequencing Panel for the Molecular Characterization of Chronic Lymphocytic Leukemia.
López-Oreja I, López-Guerra M, Correa J, Mozas P, Muntañola A, Muñoz L, Salgado AC, Ruiz-Gaspà S, Costa D, Beà S, Jares P, Campo E, Colomer D, Nadeu F. López-Oreja I, et al. Hemasphere. 2023 Sep 21;7(10):e962. doi: 10.1097/HS9.0000000000000962. eCollection 2023 Oct. Hemasphere. 2023. PMID: 37746159 Free PMC article. No abstract available.
Germ line variants in patients with acute myeloid leukemia without a suspicion of hereditary hematologic malignancy syndrome.
Guijarro F, López-Guerra M, Morata J, Bataller A, Paz S, Cornet-Masana JM, Banús-Mulet A, Cuesta-Casanovas L, Carbó JM, Castaño-Díez S, Jiménez-Vicente C, Cortés-Bullich A, Triguero A, Martínez-Roca A, Esteban D, Gómez-Hernando M, Álamo Moreno JR, López-Oreja I, Garrote M, Risueño RM, Tonda R, Gut I, Colomer D, Díaz-Beya M, Esteve J. Guijarro F, et al. Among authors: lopez oreja i. Blood Adv. 2023 Oct 10;7(19):5799-5811. doi: 10.1182/bloodadvances.2023009742. Blood Adv. 2023. PMID: 37450374 Free PMC article.
Serum soluble CD23 levels are an independent predictor of time to first treatment in chronic lymphocytic leukemia.
Piñeyroa JA, Magnano L, Rivero A, Rivas-Delgado A, Nadeu F, Correa JG, Giné E, Villamor N, Filella X, Colomer D, López M, López-Oreja I, Costa D, Aymerich M, Beà S, López-Guillermo A, Campo E, Delgado J, Mozas P. Piñeyroa JA, et al. Among authors: lopez oreja i. Hematol Oncol. 2022 Oct;40(4):588-595. doi: 10.1002/hon.3027. Epub 2022 May 28. Hematol Oncol. 2022. PMID: 35611996
12 results